Used in the treatment of peptic ulcer, gastric hyperacidity, and hypermotility in gastritis and pylorospasm, and in the treatment of hyperhidrosis (excessive perspiration).
- Mechanism
- Curator reviewed
Diphemanil Methylsulfate exerts its action by primarily binding the muscarinic M3 receptor. M3 receptors are located in the smooth muscles of the blood vessels, as well as in the lungs. This means they cause vasodilation and bronchoconstriction. They are also in the smooth muscles of the gastrointestinal tract (GIT), which help in increasing intestinal motility and dilating sphincters. The M3 receptors are also located in many glands which help to stimulate secretion in salivary glands and other glands of the body.
- Primary indication
- Used in the treatment of peptic ulcer, gastric hyperacidity, and hypermotility in gastritis and pylorospasm, and in the treatment of hyperhidrosis (excessive perspiration).Curator reviewed
- Formula / weight
- C20H24N · 278.418 g/mol (avg)
- Also known as
- Diphemanil cation · Diphemanil ion
Resolves to
LCTZPQRFOZKZNK-UHFFFAOYSA-NSMILESC[N+]1(C)CCC(CC1)=C(C1=CC=CC=C1)C1=CC=CC=C1What you can answer from here — as of September 13, 2026
Which drugs share a target with Diphemanil, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account